License and supply agreement with Genuine Health
RNS & Investor News
Issue of equity - conversion of debt, Directors dealing
02 August 2013
The Company announces that directors have converted £51,000 of liabilities owed to them into 10,200,000 ordinary shares in the Company at a price of £0.005 pence per share (the "Conversion") as set out below:-
|Name||Shares acquired by
way of the
|% of issued
The new ordinary shares will rank pari passu with the existing ordinary shares.
Application for the new ordinary shares has been made to the London Stock Exchange, trading in the new ordinary shares is expected to commence on or around 8 August 2013.
Following the above issue of equity the Company has 135,587,295 ordinary shares of 0.1 pence in issue.
For further information, please contact:
Ceres Media International PLC
Tel: 020 3178 5622
Alex Dowdeswell/Leslie Barber
Nominated Adviser, Cairn Financial Advisers
Tel: 020 7148 7900
Liam Murray/Jo Turner
Broker, XCAP Securities PLC
Tel: 202 7101 7070
Jon Belliss / Adrian Kirk
OptiBiotix Health secures significant exclusive licence agreement for OptiBiome
Stephen O'Hara | 01 Apr 2020